KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Neogenomics (NEO) Long-Term Debt Issuances: 2009-2021

Historic Long-Term Debt Issuances for Neogenomics (NEO) over the last 1 years, with Mar 2021 value amounting to $334.4 million.

  • Neogenomics' Long-Term Debt Issuances was N/A to $334.4 million in Q1 2021 from the same period last year, while for Mar 2021 it was $528.9 million, marking a year-over-year change of. This contributed to the annual value of $334.4 million for FY2021, which is 71.96% up from last year.
  • According to the latest figures from Q1 2021, Neogenomics' Long-Term Debt Issuances is $334.4 million, which was up 371,466.67% from $90,000 recorded in Q3 2020.
  • Neogenomics' 5-year Long-Term Debt Issuances high stood at $334.4 million for Q1 2021, and its period low was $90,000 during Q3 2020.
  • Over the past 2 years, Neogenomics' median Long-Term Debt Issuances value was $194.4 million (recorded in 2020), while the average stood at $176.3 million.